-
Inspiring Anchor Gift
https://braincanada.ca/about/news-updates/inspiring-anchor-giftIn 2020, Olivier Goy, an entrepreneur, activist and photography lover from France, was diagnosed with amyotrophic lateral sclerosis (ALS) – a rare neurodegenerative disease that can have many different underlying causes, presentations, and prognoses. Some patients may live with the disease for...
-
Insulin resistance in the mesolimbic system, a novel hypothesis for depression associated with metabolic resistance from obesity.
https://braincanada.ca/funded-grants/insulin-resistance-in-the-mesolimbic-system-a-novel-hypothesis-for-depression-associated-with-metabolic-resistance-from-obesityDepression and anxiety are highly prevalent in people with obesity and type 2 diabetes. Project Overview Depression and anxiety are highly prevalent in people with obesity and type 2 diabetes. There are several theories of the cause of this association, however one commonality amongst these...
-
Integrated Neurostimulation Platform for Neuropsychiatric Research
https://braincanada.ca/funded-grants/integrated-neurostimulation-platform-for-neuropsychiatric-researchThe offers the capacity to perform interleaved TMS/fMRI, a complex and demanding technique used to study brain function in neuropsychiatric disorders. Project Overview The offers the capacity to perform interleaved TMS/fMRI, a complex and demanding technique used to study brain function in...
-
Integrating multi-omics and neuroimaging to dissect crosstalk between the adaptive and innate immune systems in Alzheimer’s disease
https://braincanada.ca/funded-grants/integrating-multi-omics-and-neuroimaging-to-dissect-crosstalk-between-the-adaptive-and-innate-immune-systems-in-alzheimer-s-diseaseAlzheimer’s disease (AD) is the most common cause of dementia, affecting memory, thinking, and daily functioning. AD is characterized by the buildup of two proteins, amyloid-β and tau. Specifically, tau protein is responsible for the loss of brain cells, leading to dementia. In addition to these two...
-
Integrative discovery of ion channels as drug targets in glioblastoma
https://braincanada.ca/funded-grants/integrative-discovery-of-ion-channels-as-drug-targets-in-glioblastomaIon channel (IC) proteins are known to be involved in different human diseases such as heart and brain disorders. Project Overview Ion channel (IC) proteins are known to be involved in different human diseases such as heart and brain disorders. There are many drugs that activate or inactivate ICs...
-
Intensive Cancer Screening for Cryptogenic Stroke (INCOGNITO) Pilot Randomized Trial
https://braincanada.ca/funded-grants/intensive-cancer-screening-for-cryptogenic-stroke-incognito-pilot-randomized-trialThe first question people ask after suffering a stroke is: “Why?” Project Overview The first question people ask after suffering a stroke is: “Why?” A straightforward question, but for 4 in 10 stroke survivors, it’s also unanswerable. These are the people for whom routine tests reveal no...
-
Interleukin-1 blockade along with hypothermia to prevent cerebral palsy arising from refractory neonatal asphyxia
https://braincanada.ca/funded-grants/interleukin-1-blockade-along-with-hypothermia-to-prevent-cerebral-palsy-arising-from-refractory-neonatal-asphyxiaNeonatal asphyxia and subsequent cerebral palsy (CP) is a severe pathology resulting from lack of oxygen and/or infection-inflammation. Project Overview Neonatal asphyxia and subsequent cerebral palsy (CP) is a severe pathology resulting from lack of oxygen and/or infection-inflammation. This...
-
International collaboration to address measurement gaps in dementia care and outcomes
https://braincanada.ca/about/news-updates/international-collaboration-to-address-measurement-gaps-in-dementia-care-and-outcomesDr. Ayse Kuspinar (left), Dr. Jennifer Bethell, and Dr. Andrew Sommerlad Brain Canada and the Alzheimer’s Association are funding two Canadian-led teams for brain research that will help ensure care providers are implementing evidence-based practices and achieving desired outcomes for people living...
-
International Research Grant Program (IRGP) 2026: Alzheimer's & Dementia Research Funding
https://braincanada.ca/about/news-updates/international-research-grant-program-irgp-2026-alzheimer-s-dementia-research-fundingNew Funding Opportunities for Postdoctoral Fellows, Early-Career Investigators, and Clinician-Scientists in Alzheimer’s and Dementia Research Now Open: Funding Opportunities for Postdoctoral Fellows, Early-Career Investigators, and Clinician-Scientists in Alzheimer’s and Dementia Research Brain...
-
International Spinal Cord Injury Biobank (ISCIB): Promoting Global Spinal Cord Injury Research Through Human Biobanking
https://braincanada.ca/funded-grants/international-spinal-cord-injury-biobank-iscib-promoting-global-spinal-cord-injury-research-through-human-biobankingThe International Spinal Cord Injury Biobank (ISCIB) is a multi-user biorepository with the mission of accelerating therapeutic development in traumatic spinal cord injury (SCI) through improved biological understanding of human injury, and the vision of serving as a global research resource where...